Matthew J. Pfeffer is a finance expert with a solid background in managing financial operations in the biotech sector. He earned his bachelor’s degree from UC Berkeley and built a career with over 25 years of experience. Before becoming CEO...
Matthew J. Pfeffer is a finance expert with a solid background in managing financial operations in the biotech sector. He earned his bachelor’s degree from UC Berkeley and built a career with over 25 years of experience. Before becoming CEO of MannKind Corporation in 2016, he was Chief Financial Officer at VaxGen and Cell Genesys. His leadership at MannKind is marked by a focus on strategic financial management to support the company’s growth. Interestingly, Pfeffer’s compensation has fluctuated significantly during his time at MannKind, with total pay reaching over $3.2 million in 2016 but dropping to around $746,000 in 2017 where he also received no bonus. His use of stock options has seen impressive jumps, most recently selling insider shares worth between $106K to $503K monthly from 2019 through 2024. Pfeffer's approach blends financial discipline and an understanding of biotechnology's complexities, illustrating how crucial leadership is in navigating the biotech industry's challenges and opportunities.